Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-19-005968
Filing Date
2019-06-28
Accepted
2019-06-28 15:49:38
Documents
5
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A rsls-20181231x10ka.htm 10-K/A 270277
2 EX-31.1 rsls-20181231ex311bd73d0.htm EX-31.1 10252
3 EX-31.2 rsls-20181231ex31224c7db.htm EX-31.2 9886
4 EX-32.1 rsls-20181231ex321b82e4d.htm EX-32.1 6670
5 EX-32.2 rsls-20181231ex322ba36bb.htm EX-32.2 7446
  Complete submission text file 0001558370-19-005968.txt   305626
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

EIN.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33818 | Film No.: 19929109
SIC: 3845 Electromedical & Electrotherapeutic Apparatus